» Articles » PMID: 33445423

Prevalence of Chronic Inducible Urticaria in Elderly Patients

Overview
Journal J Clin Med
Specialty General Medicine
Date 2021 Jan 15
PMID 33445423
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Background: No data currently exist regarding the epidemiology of chronic inducible urticarias (CIndUs) in the ≥65-year-old population.

Objective: The study aimed to determine the prevalence of CIndUs among elderly patients affected by chronic urticaria (CU).

Methods: The medical records of all patients referred to us with a diagnosis of CU from January 2008 to September 2020 were retrospectively reviewed, and the patients with CIndUs were identified. The subjects aged 65 years or above were included in the study.

Results: The number of patients aged 65 years or above was 153 out of 1970 subjects affected by CU (7.77%; 92 females (60.13%); mean age 70.96 ± 4.22). Out of 153, 26 patients (16.99%; 20 females (76.9%); mean age 71.23 ± 2.6 years) were diagnosed with CIndUs. Most subjects (25/26; 96.15%) suffered from physical urticarias. Symptomatic dermographism was the most frequent, affecting 65.38% (17/26) of our patients, followed by cold urticaria (6/26 (23.08%) cases).

Conclusion: Our data seem to indicate that CIndUs may also affect the elderly, although it occurs less frequently in aging patients than in lower age groups.

Citing Articles

Chronic Urticaria in Older Adults: Treatment Considerations.

Patruno C, Fabbrocini G, Cillo F, Torta G, Stingeni L, Napolitano M Drugs Aging. 2023; 40(3):165-177.

PMID: 36808569 DOI: 10.1007/s40266-023-01010-y.


Prevalence, Clinical Manifestations, Treatment, and Clinical Course of Chronic Urticaria in Elderly: A Systematic Review.

Kulthanan K, Rujitharanawong C, Munprom K, Trakanwittayarak S, Phumariyapong P, Prasertsook S J Asthma Allergy. 2022; 15:1455-1490.

PMID: 36299736 PMC: 9590340. DOI: 10.2147/JAA.S379912.


IgE and high-affinity IgE receptor in chronic inducible urticaria, pathogenic, and management relevance.

Gimenez-Arnau A, Ribas-Llaurado C, Mohammad-Porras N, Deza G, Pujol R, Gimeno R Clin Transl Allergy. 2022; 12(2):e12117.

PMID: 35126995 PMC: 8805593. DOI: 10.1002/clt2.12117.

References
1.
Fricke J, Avila G, Keller T, Weller K, Lau S, Maurer M . Prevalence of chronic urticaria in children and adults across the globe: Systematic review with meta-analysis. Allergy. 2019; 75(2):423-432. DOI: 10.1111/all.14037. View

2.
Cataldi M, Maurer M, Taglialatela M, Church M . Cardiac safety of second-generation H -antihistamines when updosed in chronic spontaneous urticaria. Clin Exp Allergy. 2019; 49(12):1615-1623. DOI: 10.1111/cea.13500. View

3.
Xu W, Wong G, Hwang Y, Larbi A . The untwining of immunosenescence and aging. Semin Immunopathol. 2020; 42(5):559-572. PMC: 7665974. DOI: 10.1007/s00281-020-00824-x. View

4.
Maurer M, Metz M, Brehler R, Hillen U, Jakob T, Mahler V . Omalizumab treatment in patients with chronic inducible urticaria: A systematic review of published evidence. J Allergy Clin Immunol. 2017; 141(2):638-649. DOI: 10.1016/j.jaci.2017.06.032. View

5.
Farage M, Miller K, Elsner P, Maibach H . Functional and physiological characteristics of the aging skin. Aging Clin Exp Res. 2008; 20(3):195-200. DOI: 10.1007/BF03324769. View